StockVS

NASDAQ · USD

BioVie Inc. (BIVIW) Stock Analysis

BioVie Inc. (BIVIW) is a stock listed on NASDAQ and quoted in US Dollar.

BIVIW

$0.33

−$0.03 (−8.33%)

Sep 4, 2026 · Market close

This is a derivative instrument — a warrant on BioVie Inc. (BIVI) common stock.

Issuer fundamentals are shown on the issuer page, not here.

View BIVI →

Price History

Hover for the daily close. The dotted line marks the period open.

BIVIW Key Statistics

As of Sep 4, 2026
Trading
Open
$0.32
Previous Close
$0.36
Day's Range
0.32–0.35
52-Week Range
0.32–0.35
Volume
8.41K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.74

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

BIVIW Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−3.23%
2025 (partial year)+0.00%

As of September 4, 2026.

Recent News

All 8 articles ↓

News provided by third-party sources. Not financial advice.

About BioVie Inc.

BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 3 for the treatment of life-threatening complications of liver cirrhosis and ascites due to hepatitis, nonalcoholic steatohepatitis, and alcoholism. It also develops Bezisterim, an investigational, novel, orally administered small molecule that is In Phase 3 clinical trial for the treatment of patients with mild to moderate Alzheimer's disease; and in Phase 2b clinical trial to treat Parkinson's disease, as well as for the long COVID program. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.

Visit website →